Product Information

PERPHENAZINE 4 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1774 per EA under NDC 68382059201. Its NADAC has been published 299 times since Feb 24, 2021.

FDA first approved this application on Apr 6, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PERPHENAZINE 4 MG TABLET

perphenazine
$0.1774per EA

Strength

4 mg/1

NDC

68382059201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PERPHENAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA205232

FDA Approved

4/6/2020

TE Code

AB

On Market Since

7/16/2020

Pharmacological Classes

Phenothiazine
Phenothiazines

Price Statistics

The NADAC for PERPHENAZINE 4 MG TABLET has been published 299 times since Feb 24, 2021, and over the history we have for it it has declined 58.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1774 per EA
All-time high$0.4823 (May 12, 2021)
All-time low$0.1413 (Jun 17, 2026)
52-week high$0.1776
52-week low$0.1413
Median price$0.2363
Average price$0.2603
Largest weekly change+63.8% (Dec 21, 2022)
Weeks tracked299
Tracking sinceFeb 24, 2021

Price History

1W

0.0%

1M

+10.0%

3M

+5.8%

6M

+15.3%

1Y

-5.1%

3Y

-28.9%

5Y

-57.6%

All

-58.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PERPHENAZINE 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PERPHENAZINE 4 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1774 per EA (NDC 68382059201), effective Nov 11, 2026.

How has the price of PERPHENAZINE 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for PERPHENAZINE 4 MG TABLET has declined 58.0%. It has been tracked across 299 weekly CMS publications since Feb 24, 2021.

What are the highest and lowest recorded NADAC prices for PERPHENAZINE 4 MG TABLET?

Since Feb 24, 2021, the NADAC for PERPHENAZINE 4 MG TABLET has ranged from a low of $0.1413 (Jun 17, 2026) to a high of $0.4823 (May 12, 2021), with a median of $0.2363 per EA.

Are there cheaper alternatives to PERPHENAZINE 4 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PERPHENAZINE 4 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PERPHENAZINE 4 MG TABLET?

PERPHENAZINE 4 MG TABLET (NDC 68382059201) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.